Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Immunotherapy toxicities: An SGO clinical practice statement.

Publication ,  Journal Article
O'Cearbhaill, RE; Clark, L; Eskander, RN; Gaillard, S; Moroney, J; Pereira, E; Pothuri, B
Published in: Gynecol Oncol
July 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

July 2022

Volume

166

Issue

1

Start / End Page

25 / 35

Location

United States

Related Subject Headings

  • Programmed Cell Death 1 Receptor
  • Oncology & Carcinogenesis
  • Immunotherapy
  • Humans
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
O’Cearbhaill, R. E., Clark, L., Eskander, R. N., Gaillard, S., Moroney, J., Pereira, E., & Pothuri, B. (2022). Immunotherapy toxicities: An SGO clinical practice statement. Gynecol Oncol, 166(1), 25–35. https://doi.org/10.1016/j.ygyno.2022.05.003
O’Cearbhaill, R. E., L. Clark, R. N. Eskander, S. Gaillard, J. Moroney, E. Pereira, and B. Pothuri. “Immunotherapy toxicities: An SGO clinical practice statement.Gynecol Oncol 166, no. 1 (July 2022): 25–35. https://doi.org/10.1016/j.ygyno.2022.05.003.
O’Cearbhaill RE, Clark L, Eskander RN, Gaillard S, Moroney J, Pereira E, et al. Immunotherapy toxicities: An SGO clinical practice statement. Gynecol Oncol. 2022 Jul;166(1):25–35.
O’Cearbhaill, R. E., et al. “Immunotherapy toxicities: An SGO clinical practice statement.Gynecol Oncol, vol. 166, no. 1, July 2022, pp. 25–35. Pubmed, doi:10.1016/j.ygyno.2022.05.003.
O’Cearbhaill RE, Clark L, Eskander RN, Gaillard S, Moroney J, Pereira E, Pothuri B. Immunotherapy toxicities: An SGO clinical practice statement. Gynecol Oncol. 2022 Jul;166(1):25–35.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

July 2022

Volume

166

Issue

1

Start / End Page

25 / 35

Location

United States

Related Subject Headings

  • Programmed Cell Death 1 Receptor
  • Oncology & Carcinogenesis
  • Immunotherapy
  • Humans
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis